Longitudinal studies of HIV infection in intravenous drug users: Methodological issues in natural history research (DHHS publication) ebook

Sampling Issues for Natural History Studies Including Intravenous Drug Abusers

Sampling Issues for Natural History Studies Including Intravenous Drug Abusers. 5. Toward Comprehensive Studies of HIV in Intravenous Drug Users: Issues in Treatment-Based and Street-Based Samples. 6. The ALIVE Study, A Longitudinal Study Of HIV-1 Infection in Intravenous Drug Users: Description of Methods and Characteristics of Participants. 8. Potential Cofactors in the Outcomes of HIV Infection in Intravenous Drug Users.

The natural course of HIV infection in 205 intravenous drug users (IVDU) presenting at 11 centers in Italy was followed since 1983. Criteria for entering the study were spontaneous attendance at the clinic from January 1983-April 1988; history of IVDU; dated negative HIV test and a positive test not over 18 months later. 13 of the 205 subjects developed AIDS by 30 April 1988, a total of 44. 5 person-years, for an overall incidence of AIDS of . % person-years. The clinical presentation was opportunistic infections in 7, wasting syndrome in 5, and encephalopathy in 1. No Kaposi's sarcoma.

Disclaimer: The content of this publication is solely the responsibility of the authors and does not necessarily represent the views of the Beth Israel Medical Center or Johns Hopkins University.

Longitudinal Studies. Vlahov, D, Anthony, JC, Munoz, A, Margolick, JB, Nelson, KE, Celentano, DD, Solomon, L & Polk, BF 1991, 'The alive study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods', Journal of Drug Issues, vol. 21, no. 4, pp. 759-776. Vlahov D, Anthony JC, Munoz A, Margolick JB, Nelson KE, Celentano DD et al. The alive study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods. Journal of Drug Issues.

The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants.

Four academic medical centers in Baltimore, Md; Bronx, NY; Providence, RI; and Detroit, Mich. HIV-infected injection-drug users have progression to AIDS at rates comparable to those of other HIV-infected groups, but they have substantial pre-AIDS morbidity and mortality, particularly from bacterial infections, which also appear to predict disease progression.

Injection drug users (IDUs) have long been identified as a risk population for .

Injection drug users (IDUs) have long been identified as a risk population for HIV infection and may be at higher risk for kidney disease compared with the general . NIDA Res Monogr 109: 75–100, 1991.

Among the 152 injecting drug users who were initially negative for hepatitis C virus . Limitations of study. Hepatitis C virus infection in intravenous drug users: prevalence and risk factors

Among the 152 injecting drug users who were initially negative for hepatitis C virus antibody and were retested, 31 were documented as having newly acquired infection during the study period, giving an incidence of 2. per 100 person years (1. to 2. ). For these 152 subjects the median follow up was 1. (range 1 to 42) months. Several methodological issues need to be considered in the interpretation of these results. Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scand J Infect Dis1990; 22:751–752. OpenUrl PubMed Web of Science Google Scholar.

This volunteer cohort study of the natural history of HIV-1 infection in IDUs is one of a limited number of longitudinal evaluations of. .The ALIVE study: a longitudinal study of HIV-1 infection among intravenous drug users: description of methods. In: Hartsock PI, Genser SG, eds.

This volunteer cohort study of the natural history of HIV-1 infection in IDUs is one of a limited number of longitudinal evaluations of persons who are considered & IDUs'' (. IDUs who may not be in drug treatment) (2). At the time of enrollment, 24% of the cohort's members were HIV-1 seropositive. Eligibility criteria included residency in the Baltimore metropolitan area, age greater than 17 years, and history of illicit drug injection during the previous 10 years. Longitudinal studies of HIV infection.

Ethics & Behavior, 18(2-3). Addiction, 96, 1319-1325. Fry, C. Khoshnood, . Power, . & Sharma, M. (2008).

Home Browse Books Book details, HIV Infection and Intravenous Drug Us. As with many other developments, this book is the product of necessity.

Home Browse Books Book details, HIV Infection and Intravenous Drug Use. HIV Infection and Intravenous Drug Use. By Gennaro Ottomanelli. When our treatment program decided to develop AIDS prevention resources, including the HIV testing and counseling program, I was unprepared for the multitude of issues emerging from the endeavor. I was inundated by questions from patients and staff regarding every conceivable aspect of patient care including treatment protocols, confidentiality, prevention resources, interview techniques, patient management, and crisis intervention.